MU 100
Alternative Names: MU-100Latest Information Update: 03 Apr 2023
At a glance
- Originator Life Biosciences
- Class Hepatoprotectants; Small molecules
- Mechanism of Action Mitochondrial oxidative phosphorylation uncouplers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Non-alcoholic steatohepatitis
Most Recent Events
- 31 Mar 2023 Discontinued - Preclinical for Non-alcoholic steatohepatitis in USA (unspecified route)
- 25 Oct 2021 Preclinical trials in Non-alcoholic steatohepatitis in USA (unspecified route) prior to October 2021 (Life Biosciences pipeline, October 2021)